OTC simvastatin supply - What changes in practice and education do pharmacists want?

Pharmaceutical Journal

Volumn 273, Issue 7311, 2004, Pages 191-193

  Blenkinsopp, John ^a   Gathoga, Lydia ^a   O'Connell, Kate ^a   Mukhtar, Muddassir ^a   Rehman, Irim ^a   Shan, Naheed ^a   Tariq, Moheed ^a  

^a UNIVERSITY OF BRADFORD   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; NON PRESCRIPTION DRUG; SIMVASTATIN;

ADULT; ARTICLE; CARDIOVASCULAR RISK; CONSULTATION; DIETARY INTAKE; FEMALE; HUMAN; ISCHEMIC HEART DISEASE; LIFESTYLE; MALE; MEDICAL RECORD; PARAMEDICAL EDUCATION; PHARMACIST; POSTGRADUATE EDUCATION; PRESCRIPTION; PROFESSIONAL PRACTICE;

EID: 4444361308     PISSN: 00316873     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (3)

1. National service framework for coronary heart disease. London: Department of Health; 2000. Available at: www.doh.gov.uk/nsf/coronary.htm (accessed March 1, 2004)
2. Delivering better health services: progress report 2003. London: Department of Health; 2003. Available at: www.doh.gov.uk (accessed March 2, 2004)
3. Royal Pharmaceutical Society. Practice guidance: OTC simvastatin 10mg. Pharmaceutical Journal 2004;273: 169-70.